Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Single Pass
AddedFeb 19, 2024
UpdatedJun 18, 2026
Single Pass

Single Pass

Seed

Single Pass, based in Lake Forest, CA, develops disposable devices for deep tissue cauterization.

HQ
Lake Forest, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Single Pass, based in Lake Forest, California, is dedicated to advancing medical technology with its innovative disposable bipolar electrocautery device. The company's core mission is to enhance the safety and efficiency of biopsy procedures by preventing bleeding through deep tissue cauterization. Their patented device, designed for single-use, aims to make biopsy processes swift, easy, and safe, addressing a significant need in the medical field for reliable and effective bleeding control during solid organ biopsies.

Notable figures associated with Single Pass include its founding team of medical and engineering experts who have driven the development of this groundbreaking technology. The company has garnered attention and support from key investors in the medical device sector. Single Pass's achievements include securing patents for their unique device and gaining recognition for improving patient outcomes in biopsy procedures. Their impact is marked by enhanced procedural safety and efficiency, contributing to better healthcare practices and patient care.

Single Pass - Similar Companies

Swift Sync logo

Swift Sync

swiftsync.net

Instapath Inc. logo

Instapath Inc.

instapathbio.com

Opus KSD logo

Opus KSD

subq-it.com

Portal Instruments logo

Portal Instruments

Encapsule Medical logo

Encapsule Medical

encapsule.com

V-Flow Medical logo

V-Flow Medical

Limber Technologies logo

Limber Technologies

limber.life

PulzAid logo

PulzAid

pulzaid.com

dopl technologies logo

dopl technologies

Digital Medical Tech logo

Digital Medical Tech

VenoStent logo

VenoStent

venostent.com

SiPhox Health logo

SiPhox Health

siphox.com

Taproot Medical Technologies logo

Taproot Medical Technologies

taprootmedical.com

Radux Devices logo

Radux Devices

raduxdevices.com

Auricle logo

Auricle

auricle.com

Single Pass - Quick Facts

Who are Single Pass' competitors?

Companies similar to Single Pass include Swift Sync, Instapath Inc., Opus KSD and Portal Instruments.

When was Single Pass founded?

Single Pass was founded in 2021.

Where is Single Pass' headquarters located?

Single Pass' headquarters is located in Lake Forest, CA, US.

When was Single Pass' last funding round?

Single Pass' most recent funding round was for $460k (USD) in August 2022.

How much has Single Pass raised to-date?

As of Aug 2, 2022, Single Pass has raised a total of $460k (USD).

How many employees does Single Pass have?

Single Pass has 5 employees as of Feb 5, 2024.

Single Pass - Classification

Industry
  • Hardware
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified